Subsidiary19 Aug 2026, 06:30 pm
Dr. Lal PathLabs Subsidiary Incorporates Entity in Uzbekistan
AI Summary
Dr. Lal PathLabs FZCO, a wholly-owned subsidiary in Dubai, has incorporated a new entity named "Dr Lal PathLabs Indomed LLC" in Tashkent, Uzbekistan, on August 19, 2026. The subsidiary will subscribe to 70% of the new entity's share capital. This move aims to strengthen the Group's presence in Tashkent and expand its diagnostic services business. The incorporation is a step towards establishing a new operational base in Uzbekistan.
Key Highlights
- Subsidiary incorporated a new entity in Tashkent, Uzbekistan.
- Will subscribe to 70% of the new entity's share capital.
- Objective is to strengthen presence in Tashkent and expand diagnostic services.
- The new entity is a step-down subsidiary.
Price Impact
More from LALPATHLAB